Last updated: June 5, 2026

Back to directory

RayStation Deep Learning Segmentation medical AI product profile

RaySearch RayStation module that uses deep-learning segmentation models to generate radiation therapy contours inside the treatment-planning environment.

Screenshot of the official RayStation Deep Learning Segmentation product page
Medical imaging and radiology

Best fit

Cancer centers already using or evaluating RayStation that want AI segmentation tightly integrated with treatment planning and can commission site-specific review workflows.

Primary use case
Deep-learning organ segmentation inside RayStation, radiation therapy contour generation, automated planning support, and treatment-planning workflow consistency
Audience
Radiation oncology departments, dosimetrists, medical physicists, treatment-planning administrators, and cancer-center AI governance committees
Risk level
High
Pricing signal
RayStation enterprise licensing varies by module, market, release, service contract, and treatment-planning configuration; verify current DLS availability and regulatory clearance.
Official sources
5 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating RayStation Deep Learning Segmentation as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as high-risk radiation oncology treatment-planning software and verify the exact RayStation release, 510(k) or local authorization, enabled model, modality, anatomy, and market restriction before production use.
PrivacyReview RayStation deployment architecture, image and contour storage, support access, scripting, logs, connected services, retention, BAA or data-processing terms, and whether model updates use customer data.
EvidenceCommission DLS performance by cancer site, scanner, protocol, contouring guideline, physician edit burden, abnormal anatomy, artifacts, and treatment-plan impact rather than relying only on vendor time-savings claims.
WorkflowBest governed as an integrated contouring and planning accelerator with radiation oncologist review, dosimetrist editing, physicist QA, documented exceptions, and manual fallback for unsupported cases.

Where RayStation Deep Learning Segmentation fits

RaySearch describes machine-learning features in RayStation for automated plan generation and organ segmentation, with deep-learning segmentation models released with RayStation versions and subject to market-specific regulatory clearance; RaySearch's FDA clearance announcement and FDA 510(k) summary for RayStation 8.1 document machine-learning planning and segmentation functionality.

Not for: Unreviewed contour acceptance, autonomous treatment decisions, assuming dose-prediction claims apply in the U.S. or Canada, or use outside the cleared release, market, modality, and model catalogue.

What to verify before using RayStation Deep Learning Segmentation

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products